Decreased incidence of cytomegalovirus infection in thymoglobulin-treated transplant patients with 6 months of valganciclovir prophylaxis

被引:26
作者
Akalin, E [1 ]
Bromberg, JS [1 ]
Sehgal, V [1 ]
Ames, S [1 ]
Murphy, B [1 ]
机构
[1] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY 10029 USA
关键词
D O I
10.1046/j.1600-6143.2003.00308.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:148 / 149
页数:2
相关论文
共 4 条
[1]   Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis [J].
Akalin, E ;
Sehgal, V ;
Ames, S ;
Hossain, S ;
Daly, L ;
Barbara, M ;
Bromberg, JS .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (06) :731-735
[2]  
Brennan DC, 2001, J AM SOC NEPHROL, V12, P848, DOI 10.1681/ASN.V124848
[3]   Pharmacokinetics of valganciclovir and ganciclovir in renal impairment [J].
Czock, D ;
Scholle, C ;
Rasche, FM ;
Schaarschmidt, D ;
Keller, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (02) :142-150
[4]  
PAYA CV, 2002, INT C ANT AG CHEM SE